Loading clinical trials...
Loading clinical trials...
A Randomized Phase 2 Study of Ixabepilone Plus Carboplatin and Paclitaxel Plus Carboplatin in Patients With Advanced Non-small Cell Lung Cancer
Conditions
Interventions
Ixabepilone, 32 mg/m^2
Paclitaxel, 200 mg/m^2
+1 more
Locations
33
United States
Scripps Cancer Center
La Jolla, California, United States
Uof Md,Greenebaum Cancer Ctr.
Baltimore, Maryland, United States
Local Institution
Capital Federal, Buenos Aires, Argentina
Local Institution
Capital Federal, Buenos Aires, Argentina
Local Institution
Buenos Aires, Argentina
Local Institution
Bankstown, New South Wales, Australia
Start Date
December 1, 2008
Primary Completion Date
May 1, 2010
Completion Date
August 1, 2011
Last Updated
October 28, 2020
NCT06590194
NCT05767892
Lead Sponsor
R-Pharm
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions